Annual CFI:
-$63.00M+$6.19M(+8.95%)Summary
- As of today, AMRX annual cash from investing is -$63.00 million, with the most recent change of +$6.19 million (+8.95%) on December 31, 2024.
- During the last 3 years, AMRX annual cash from investing has risen by +$131.19 million (+67.56%).
- AMRX annual cash from investing is now -278.12% below its all-time high of $35.37 million, reached on December 1, 2005.
Performance
AMRX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
-$26.55M-$8.75M(-49.16%)Summary
- As of today, AMRX quarterly cash from investing is -$26.55 million, with the most recent change of -$8.75 million (-49.16%) on June 30, 2025.
- Over the past year, AMRX quarterly cash from investing has dropped by -$20.08 million (-310.63%).
- AMRX quarterly cash from investing is now -145.93% below its all-time high of $57.80 million, reached on March 1, 2012.
Performance
AMRX Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$81.12M-$20.08M(-32.90%)Summary
- As of today, AMRX TTM cash from investing is -$81.12 million, with the most recent change of -$20.08 million (-32.90%) on June 30, 2025.
- Over the past year, AMRX TTM cash from investing has dropped by -$9.72 million (-13.62%).
- AMRX TTM cash from investing is now -291.41% below its all-time high of $42.38 million, reached on December 1, 2008.
Performance
AMRX TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
AMRX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +8.9% | -310.6% | -13.6% |
| 3Y3 Years | +67.6% | -64.7% | +61.8% |
| 5Y5 Years | -172.4% | -197.4% | +72.4% |
AMRX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +67.6% | -310.6% | +46.2% | -60.0% | +67.5% |
| 5Y | 5-Year | -172.4% | +80.4% | -310.6% | +72.7% | -60.0% | +74.7% |
| All-Time | All-Time | -278.1% | +90.0% | -145.9% | +95.5% | -291.4% | +87.1% |
AMRX Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$26.55M(-49.2%) | -$81.12M(-32.9%) |
| Mar 2025 | - | -$17.80M(-10.8%) | -$61.03M(+3.1%) |
| Dec 2024 | -$63.00M(+9.0%) | -$16.06M(+22.5%) | -$63.00M(+19.9%) |
| Sep 2024 | - | -$20.71M(-220.4%) | -$78.63M(-10.1%) |
| Jun 2024 | - | -$6.46M(+67.3%) | -$71.39M(+7.5%) |
| Mar 2024 | - | -$19.76M(+37.6%) | -$77.21M(-11.6%) |
| Dec 2023 | -$69.19M(+60.7%) | -$31.69M(-135.2%) | -$69.19M(-36.5%) |
| Sep 2023 | - | -$13.48M(-9.7%) | -$50.69M(+41.4%) |
| Jun 2023 | - | -$12.28M(-4.7%) | -$86.54M(+4.2%) |
| Mar 2023 | - | -$11.74M(+11.0%) | -$90.37M(+48.7%) |
| Dec 2022 | -$176.03M(+9.3%) | -$13.19M(+73.3%) | -$176.03M(+29.5%) |
| Sep 2022 | - | -$49.33M(-206.1%) | -$249.81M(-17.8%) |
| Jun 2022 | - | -$16.12M(+83.5%) | -$212.11M(+23.9%) |
| Mar 2022 | - | -$97.39M(-12.0%) | -$278.88M(-43.6%) |
| Dec 2021 | -$194.18M(+39.5%) | -$86.97M(-647.6%) | -$194.18M(-39.7%) |
| Sep 2021 | - | -$11.63M(+86.0%) | -$139.01M(+4.4%) |
| Jun 2021 | - | -$82.89M(-553.0%) | -$145.46M(-103.4%) |
| Mar 2021 | - | -$12.69M(+60.1%) | -$71.50M(+77.7%) |
| Dec 2020 | -$320.85M(-1287.6%) | -$31.80M(-75.8%) | -$320.85M(-9.2%) |
| Sep 2020 | - | -$18.08M(-102.6%) | -$293.82M(-19.6%) |
| Jun 2020 | - | -$8.93M(+96.6%) | -$245.75M(+6.1%) |
| Mar 2020 | - | -$262.04M(-5397.0%) | -$261.69M(-1031.7%) |
| Dec 2019 | -$23.12M(+94.3%) | -$4.77M(-115.9%) | -$23.12M(-77.4%) |
| Sep 2019 | - | $29.98M(+220.6%) | -$13.04M(+86.4%) |
| Jun 2019 | - | -$24.86M(-5.9%) | -$95.57M(+76.8%) |
| Mar 2019 | - | -$23.48M(-541.2%) | -$412.13M(-1.0%) |
| Dec 2018 | -$408.15M(-314.1%) | $5.32M(+110.1%) | -$408.15M(+3.4%) |
| Sep 2018 | - | -$52.55M(+84.6%) | -$422.38M(-4.3%) |
| Jun 2018 | - | -$341.43M(-1651.0%) | -$404.87M(-538.2%) |
| Mar 2018 | - | -$19.50M(-119.1%) | -$63.44M(-44.4%) |
| Dec 2017 | -$98.55M(+84.3%) | -$8.90M(+74.6%) | -$43.94M(+23.3%) |
| Sep 2017 | - | -$35.04M(-57.3%) | -$57.32M(+90.9%) |
| Dec 2016 | -$627.09M(-34.1%) | - | - |
| Dec 2016 | - | -$22.28M(+96.3%) | -$627.09M(-1.1%) |
| Sep 2016 | - | -$597.15M(-8991.4%) | -$620.35M(-2041.8%) |
| Jun 2016 | - | $6.72M(+146.7%) | $31.95M(+107.1%) |
| Mar 2016 | - | -$14.38M(+7.5%) | $15.42M(+103.3%) |
| Dec 2015 | -$467.54M(-2716.3%) | -$15.54M(-128.2%) | -$467.54M(-11.1%) |
| Sep 2015 | - | $55.15M(+662.3%) | -$420.71M(+11.9%) |
| Jun 2015 | - | -$9.81M(+98.0%) | -$477.54M(-1.6%) |
| Mar 2015 | - | -$497.34M(-1689.6%) | -$469.85M(-2730.3%) |
| Dec 2014 | -$16.60M(+85.7%) | $31.29M(+1971.3%) | -$16.60M(+82.2%) |
| Sep 2014 | - | -$1.67M(+21.3%) | -$93.31M(-33.9%) |
| Jun 2014 | - | -$2.12M(+95.2%) | -$69.70M(+55.4%) |
| Mar 2014 | - | -$44.09M(+2.9%) | -$156.10M(-34.7%) |
| Dec 2013 | -$115.89M | -$45.43M(-307.0%) | -$115.89M(-86.8%) |
| Sep 2013 | - | $21.95M(+124.8%) | -$62.05M(+63.6%) |
| Jun 2013 | - | -$88.53M(-2179.9%) | -$170.68M(-15.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | -$3.88M(-146.1%) | -$147.46M(-71.9%) |
| Dec 2012 | -$85.78M(-470.2%) | $8.41M(+109.7%) | -$85.78M(+32.2%) |
| Sep 2012 | - | -$86.69M(-32.7%) | -$126.48M(-86.8%) |
| Jun 2012 | - | -$65.31M(-213.0%) | -$67.71M(-1857.3%) |
| Mar 2012 | - | $57.80M(+279.0%) | $3.85M(+125.6%) |
| Dec 2011 | -$15.04M(+93.0%) | -$32.29M(-15.7%) | -$15.04M(+71.2%) |
| Sep 2011 | - | -$27.91M(-546.4%) | -$52.25M(+24.2%) |
| Jun 2011 | - | $6.25M(-83.9%) | -$68.89M(+62.5%) |
| Mar 2011 | - | $38.90M(+156.0%) | -$183.66M(+14.0%) |
| Dec 2010 | -$213.63M(-880.6%) | -$69.49M(-55.9%) | -$213.63M(-37.2%) |
| Sep 2010 | - | -$44.56M(+58.9%) | -$155.71M(-47.0%) |
| Jun 2010 | - | -$108.52M(-1315.0%) | -$105.92M(>-9900.0%) |
| Mar 2010 | - | $8.93M(+177.2%) | $591.00K(+102.7%) |
| Dec 2009 | -$21.79M(-167.4%) | -$11.57M(-321.1%) | -$21.79M(-119.1%) |
| Sep 2009 | - | $5.23M(+360.8%) | -$9.94M(-136.9%) |
| Jun 2009 | - | -$2.01M(+85.1%) | $26.93M(-6.9%) |
| Mar 2009 | - | -$13.45M(-4971.7%) | $28.93M(-31.7%) |
| Dec 2008 | $32.33M(+132.9%) | $276.00K(-99.3%) | $42.38M(+0.7%) |
| Sep 2008 | - | $42.10M(+2205.2%) | $42.10M(+176.8%) |
| Dec 2007 | -$98.29M(-124.9%) | - | - |
| Dec 2006 | -$43.70M(-223.6%) | - | - |
| Dec 2005 | $35.37M(+903.4%) | - | - |
| Sep 2004 | - | -$2.00M(+96.0%) | -$54.85M(-34.2%) |
| Jun 2004 | - | -$49.49M(-2343.9%) | -$40.87M(-613.4%) |
| Mar 2004 | - | -$2.02M(-51.2%) | -$5.73M(-30.1%) |
| Dec 2003 | -$4.40M(-182.0%) | -$1.34M(-111.2%) | -$4.40M(+19.4%) |
| Sep 2003 | - | $11.98M(+183.5%) | -$5.46M(+64.6%) |
| Jun 2003 | - | -$14.35M(-1955.4%) | -$15.42M(-1019.6%) |
| Mar 2003 | - | -$698.00K(+70.9%) | -$1.38M(-125.7%) |
| Dec 2002 | $5.37M(+118.4%) | -$2.40M(-218.3%) | $5.37M(-49.7%) |
| Sep 2002 | - | $2.03M(+760.9%) | $10.68M(+139.6%) |
| Jun 2002 | - | -$307.00K(-105.1%) | -$26.97M(+3.7%) |
| Mar 2002 | - | $6.05M(+108.0%) | -$28.00M(+4.2%) |
| Dec 2001 | -$29.22M(-157.6%) | $2.91M(+108.2%) | -$29.22M(+22.8%) |
| Sep 2001 | - | -$35.62M(-2572.1%) | -$37.85M(>-9900.0%) |
| Jun 2001 | - | -$1.33M(-127.6%) | $151.00K(-97.2%) |
| Mar 2001 | - | $4.83M(+184.3%) | $5.34M(+147.1%) |
| Dec 2000 | -$11.34M(-1308.0%) | -$5.73M(-340.2%) | -$11.34M(-219.2%) |
| Sep 2000 | - | $2.38M(-38.2%) | -$3.55M(+45.0%) |
| Jun 2000 | - | $3.86M(+132.6%) | -$6.46M(+34.9%) |
| Mar 2000 | - | -$11.86M(-675.7%) | -$9.93M(-1157.1%) |
| Dec 1999 | $939.00K(+331.9%) | $2.06M(+492.4%) | $939.00K(+184.6%) |
| Sep 1999 | - | -$525.00K(-231.6%) | -$1.11M(-80.5%) |
| Jun 1999 | - | $399.00K(+140.1%) | -$615.00K(+42.4%) |
| Mar 1999 | - | -$995.00K(-9145.5%) | -$1.07M(-163.5%) |
| Dec 1998 | -$405.00K | $11.00K(+136.7%) | -$405.00K(+2.6%) |
| Sep 1998 | - | -$30.00K(+43.4%) | -$416.00K(-7.8%) |
| Jun 1998 | - | -$53.00K(+84.1%) | -$386.00K(-15.9%) |
| Mar 1998 | - | -$333.00K | -$333.00K |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual cash from investing?
- What is the all-time high annual cash from investing for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual cash from investing year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly cash from investing?
- What is the all-time high quarterly cash from investing for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
- What is Amneal Pharmaceuticals, Inc. TTM cash from investing?
- What is the all-time high TTM cash from investing for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. TTM cash from investing year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual cash from investing?
The current annual cash from investing of AMRX is -$63.00M
What is the all-time high annual cash from investing for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual cash from investing is $35.37M
What is Amneal Pharmaceuticals, Inc. annual cash from investing year-on-year change?
Over the past year, AMRX annual cash from investing has changed by +$6.19M (+8.95%)
What is Amneal Pharmaceuticals, Inc. quarterly cash from investing?
The current quarterly cash from investing of AMRX is -$26.55M
What is the all-time high quarterly cash from investing for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly cash from investing is $57.80M
What is Amneal Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
Over the past year, AMRX quarterly cash from investing has changed by -$20.08M (-310.63%)
What is Amneal Pharmaceuticals, Inc. TTM cash from investing?
The current TTM cash from investing of AMRX is -$81.12M
What is the all-time high TTM cash from investing for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high TTM cash from investing is $42.38M
What is Amneal Pharmaceuticals, Inc. TTM cash from investing year-on-year change?
Over the past year, AMRX TTM cash from investing has changed by -$9.72M (-13.62%)